These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16426087)

  • 1. Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.
    Rickels K; Rynn M; Iyengar M; Duff D
    J Clin Psychiatry; 2006 Jan; 67(1):41-7. PubMed ID: 16426087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder.
    Stocchi F; Nordera G; Jokinen RH; Lepola UM; Hewett K; Bryson H; Iyengar MK;
    J Clin Psychiatry; 2003 Mar; 64(3):250-8. PubMed ID: 12716265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
    Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
    J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission rates in patients with anxiety disorders treated with paroxetine.
    Ballenger JC
    J Clin Psychiatry; 2004 Dec; 65(12):1696-707. PubMed ID: 15641876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.
    Rickels K; Zaninelli R; McCafferty J; Bellew K; Iyengar M; Sheehan D
    Am J Psychiatry; 2003 Apr; 160(4):749-56. PubMed ID: 12668365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
    Ball SG; Kuhn A; Wall D; Shekhar A; Goddard AW
    J Clin Psychiatry; 2005 Jan; 66(1):94-9. PubMed ID: 15669894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
    Liebowitz MR; Gelenberg AJ; Munjack D
    Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder.
    Bielski RJ; Bose A; Chang CC
    Ann Clin Psychiatry; 2005; 17(2):65-9. PubMed ID: 16075658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.
    Rosenthal M
    J Clin Psychiatry; 2003 Oct; 64(10):1245-9. PubMed ID: 14658975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.
    Davidson JR; Bose A; Wang Q
    J Clin Psychiatry; 2005 Nov; 66(11):1441-6. PubMed ID: 16420082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.
    Liebowitz MR; Stein MB; Tancer M; Carpenter D; Oakes R; Pitts CD
    J Clin Psychiatry; 2002 Jan; 63(1):66-74. PubMed ID: 11838629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.
    Golden RN; Nemeroff CB; McSorley P; Pitts CD; Dubé EM
    J Clin Psychiatry; 2002 Jul; 63(7):577-84. PubMed ID: 12143913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis.
    Roy-Byrne PP; Perera P; Pitts CD; Christi JA
    J Clin Psychiatry; 2005 Oct; 66(10):1228-33. PubMed ID: 16259535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
    Ravindran AV; Judge R; Hunter BN; Bray J; Morton NH
    J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder.
    Kim TS; Pae CU; Yoon SJ; Bahk WM; Jun TY; Rhee WI; Chae JH
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):347-51. PubMed ID: 16732752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balneotherapy versus paroxetine in the treatment of generalized anxiety disorder.
    Dubois O; Salamon R; Germain C; Poirier MF; Vaugeois C; Banwarth B; Mouaffak F; Galinowski A; Olié JP
    Complement Ther Med; 2010 Feb; 18(1):1-7. PubMed ID: 20178872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine in the treatment of generalised anxiety disorder.
    Snyderman SH; Rynn MA; Bellew K; Rickels K
    Expert Opin Pharmacother; 2004 Aug; 5(8):1799-806. PubMed ID: 15264994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.